Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study

@inproceedings{BodzentaLukaszyk2011FluticasoneformoterolCT,
  title={Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study},
  author={Anna Bodzenta-Lukaszyk and Andrzej Dymek and Kirsten McAulay and Heikki Mansikka},
  booktitle={BMC pulmonary medicine},
  year={2011}
}
BACKGROUND The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting β2-agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoterol, flutiform ®) in a single aerosol inhaler. This 12-week, open-label, randomized, active-controlled, parallel-group, multicentre, phase 3 study compared the efficacy and safety of fluticasone/formoterol with the commercially available combination product fluticasone… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial

International journal of chronic obstructive pulmonary disease • 2017

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Update on asthma control in five European countries: results of a 2008 survey.

European respiratory review : an official journal of the European Respiratory Society • 2010
View 1 Excerpt

Similar Papers

Loading similar papers…